3月2日,爵士制药(JAZZ.US)公布财报,公告显示公司2024财年净利润为5.60亿美元,同比增加34.94%;其中营业收入为40.69亿美元,同比增加6.13%,每股基本收益为9.06美元。从资产负债表来看,爵士制药(JAZZ.US)总负债79.19亿美元,其中短期债务45.78百万美元,资产负债比为1.52,流动比率为4.46。机构评级:截至2025年3月2日,当前有17家机构对爵士制药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.